The adoptive transfer of genetically engineered T cells expressing chimeric antigen receptors (CARs) has emerged as a transformative cancer therapy with curative potential, precipitating a wave of preclinical and clinical studies in academic centers and the private sector. Indeed, significant effort has been devoted to improving clinical benefit by incorporating accessory genes/CAR endodomains designed to enhance cellular migration, promote expansion/persistence or enhance safety by genetic programming to enable the recognition of a tumor signature. However, our efforts centered on exploring whether CAR T-cell potency could be enhanced by modifying pre-existing CAR components. We now demonstrate how molecular refinements to the CAR spacer can impact multiple biological processes including tonic signaling, cell aging, tumor localization, and antigen recognition, culminating in superior antitumor activity.
Download full-text PDF |
Source |
|---|---|
| http://www.ncbi.nlm.nih.gov/pmc/articles/PMC5214260 | PMC |
| http://dx.doi.org/10.1080/2162402X.2016.1253656 | DOI Listing |
Publication Analysis
Top Keywords
Similar Publications
Disulfide-Containing Nitrosoarenes: Synthesis and Insights into Their Self-Polymerization on a Gold Surface.
Langmuir
December 2024
Department of Chemistry, Faculty of Science, University of Zagreb, Horvatovac 102A, HR-10000 Zagreb, Croatia.
Disulfide-containing nitrosoarenes with [bis(4-nitrosobenzyl) disulfide, ()] or without [4-nitrosophenyl disulfide, (), and 1,2-bis(4'-nitroso-[1,1'-biphenyl]-4-yl)disulfane, ()] an alkyl spacer between the sulfur headgroup and the aromatic moiety (phenyl in () or biphenyl in ()) were synthesized and used as precursors to form azodioxy thiolate films on Au(111) substrates. Due to the incorporated disulfide functionalities, these specifically designed nitrosoarenes are enabled to self-polymerize through azodioxy bonds on a gold surface. Thin films of (), (), and () were prepared at different adsorption times via the solution-phase self-assembly of molecules onto the Au(111) surface and characterized by Raman spectroscopy, ellipsometry, water contact angle measurements, atomic force microscopy (AFM), and scanning tunneling microscopy (STM).
View Article and Find Full Text PDFComparison of commonly used software pipelines for analyzing fungal metabarcoding data.
BMC Genomics
November 2024
Department of Microbiology, Universität Innsbruck, Innsbruck, Austria.
Article Synopsis
- Metabarcoding of the ITS region is widely used to study fungal communities, but the lack of standardized bioinformatic pipelines leads to varying results.
- This study compared DADA2, which infers ASVs, and mothur, which clusters sequences into OTUs, revealing that mothur identified greater fungal richness and produced more consistent results across multiple samples.
- The findings suggest that using a 97% similarity threshold for OTU clustering may be the best method for analyzing fungal metabarcoding data to reduce potential bias.
CAR spacers: Not just filling space.
Mol Ther
October 2024
Translational Oncology Laboratory, Centre for Cancer Biology, SA Pathology and University of South Australia, Adelaide, SA 5000, Australia; RAH Cancer Clinical Trials Unit, Royal Adelaide Hospital, Adelaide, SA 5000, Australia; Adelaide Medical School, The University of Adelaide, Adelaide, SA 5005, Australia. Electronic address:
Optimization of anti-TIM3 chimeric antigen receptor with CD8α spacer and TNFR-based costimulation for enhanced efficacy in AML therapy.
Biomed Pharmacother
October 2024
Department of Pharmacology and Physiology, Faculty of Pharmaceutical Sciences, Chulalongkorn University, Bangkok, Thailand; Cellular Immunotherapy Research Unit, Chulalongkorn University, Bangkok, Thailand; Thailand Hub of Talents in Cancer Immunotherapy (TTCI), Bangkok, Thailand. Electronic address:
CAR T cell therapy for AML remains limited due to the lack of a proper target without on-target off-tumor toxicity. TIM3 is a promising target due to its high expression on AML cells and absence in most normal hematopoietic cells. Previous reports have shown that each CAR component impacts CAR functionality.
View Article and Find Full Text PDFNext-generation BCMA-targeted chimeric antigen receptor CARTemis-1: the impact of manufacturing procedure on CAR T-cell features.
Cell Oncol (Dordr)
August 2024
Instituto de Biomedicina de Sevilla, IBiS/Hospital Universitario Virgen del Rocío/CSIC/Universidad de Sevilla, Sevilla, Spain.
Article Synopsis
- CAR therapy targeting BCMA is being improved with the new anti-BCMA CAR called CARTemis-1, which aims to be more effective against multiple myeloma, addressing the challenges of current treatments that lack sustained effectiveness.
- The study demonstrated that the longer version of CARTemis-1 showed better cancer-killing ability and confirmed that certain manufacturing conditions, like specific cytokines, enhance CAR-T cell quality and effectiveness.
- CARTemis-1 was found to be effective without being inhibited by soluble BCMA, and it successfully met regulatory standards for production while exhibiting strong antitumor effects in both lab and live models.
Want AI Summaries of new PubMed Abstracts delivered to your In-box?
Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!